GH - Guardant Health slips as FDA comments on cancer screening test
2024-05-21 11:05:08 ET
More on Guardant Health
- Guardant Health, Inc. (GH) Q1 2024 Earnings Call Transcript
- Guardant Health: Shield Launch Could Drive Multiple Expansion
- Guardant Health, Inc. (GH) Q4 2023 Earnings Call Transcript
- Guardant Health Non-GAAP EPS of -$0.46 beats by $0.27, revenue of $168.5M beats by $18.43M
- Guardant Health Q1 2024 Earnings Preview